Healthcare use and clinical investigations before a diagnosis of ovarian cancer: a register-based study in Denmark

Author:

Rousing Isabella Gringer,Vedsted Peter,Hjertholm Peter,Kallestrup Per,Baun Marie-Louise Ladegaard,Virgilsen Line Flytkjaer

Abstract

Abstract Background Ovarian cancer (OC) is associated with a poor prognosis, which calls for earlier diagnosis. This study aimed to analyse the health care use in primary care and at hospitals among women with OC compared to non-cancerous women to identify a window of opportunity for earlier diagnosis. Methods This nationwide register-based observational cohort study included all Danish women aged ≥ 40 years who were diagnosed with a first-time OC or borderline ovarian tumour in 2012–2018 and with no previous cancer diagnosis (n = 4,255). For each case, ten non-cancerous women were identified (n = 42,550). We estimated monthly incidence rate ratios using a negative binomial regression model to assess the use of health care services. We calculated risk ratios of having multiple contacts to general practice before a diagnosis using a binary regression model. Results Cases had statistically significantly higher contact rates to general practice from five months prior to the diagnosis compared to references. From six to eight months prior to diagnosis, an increased use of transvaginal ultrasound and gynaecologist was seen for cases compared to references. Conclusions Increased healthcare use was seen relatively closely to the time of diagnosis for women with OC. This indicates a narrow window of opportunity for a timelier diagnosis. Still, the use of specialised assessment increased at six to eight months before the diagnosis. When women present unspecific symptoms, awareness of potential ovarian malignancies and safety-netting by the general practitioner may be pivotal. Trial registration Not relevant.

Publisher

Springer Science and Business Media LLC

Subject

Family Practice

Reference34 articles.

1. Danmark NORDCAN, Aeggestok mv. 2015–2019 [Ovaries, oviduct, etc. 2015–2019] https://gco.iarc.fr/media/nordcan/factsheets/91/dk/countries/208/ggestok_ggeleder_mv-220-danmark-208.pdf. Accessed 9 January 2022.

2. Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, et al. Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol. 2012;127:75–82.

3. Dansk Gynaekologisk Cancer Database, National Aarsrapport. 2017/2018 og 2018/2019 [The Danish Gynaecological Cancer Database, Annual Report 2017/2018 and 2018/2019] http://www.dgcg.dk/images/rsrapport_DGCD_2017-19.pdf. Accessed 25 August 2022.

4. Grossman DC, Curry SJ, Owens DK, Barry MJ, Davidson KW, Doubeni CA, et al. Screening for ovarian Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319:588–94.

5. Ladegaard Baun ML, Falborg AZ, Hjertholm P, Petersen LK, Vedsted P. Ovarian cancer stage, variation in transvaginal ultrasound examination rates and the impact of an urgent referral pathway: a national ecological cohort study. Acta Obstet Gynecol Scand. 2019;98:1540–8.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3